Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Precision BioSciences

Precision BioSciences?uq=UG6efJS6
2006 FOUNDED
PRIVATE STATUS
41-50 EMPLOYEES
Series B LATEST DEAL TYPE
$110M LATEST DEAL AMOUNT
24 INVESTORS
Description

Developer of therapeutics and services based on genomic molecular biology designed to eliminate cancers. The company's technology works to cure genetic diseases and create safer, more productive food sources through genome editing, enabling the food and health industries to advance new solutions to major obstacles currently faced.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Primary Office
  • 302 East Pettigrew Street
  • Dibrell Building, Suite A-100
  • Durham, NC 27701
  • United States

+1 (919) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Precision BioSciences’s full profile, request a free trial.

Precision BioSciences Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series B) 26-Jun-2018 $110M 00000 Completed Generating Revenue
4. Secondary Transaction - Private 00000 Completed Generating Revenue
3. Grant 23-May-2016 00.00 00000 Completed Generating Revenue
2. Corporate 25-Feb-2016 $105M $131M Completed Generating Revenue
1. Later Stage VC (Series A) 11-May-2015 $25.6M $25.6M 00000 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Precision BioSciences Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series B 00,000,000 00.000000 00.00 00.00 00 00.00 00.000
Series A 00,000,000 00.000000 00 00 00 00 00.000
To view this company’s complete Cap Table, request access »

Precision BioSciences Investors (24)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Adage Capital Management Hedge Fund Minority 000 0000 000000 0
Agent Capital Venture Capital Minority 000 0000 000000 0
Alexandria Venture Investments Corporate Venture Capital Minority 000 0000 000000 0
ArrowMark Partners Asset Manager Minority 000 0000 000000 0
Brace Pharma Capital Corporate Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 24 investors. Get the full list »

Precision BioSciences Executive Team (12)

Name Title Board
Seat
Contact
Info
Matthew Kane Co-Founder, Chief Executive Officer & Board Member
Todd Melby Chief Financial Officer & Chief Operations Officer
Jeff Smith Ph.D Co-Founder & Chief Technology Officer
David Thomson Ph.D Chief Development Officer
Derek Jantz Co-Founder, Chief Scientific Officer & Board Member

1 Former Executive

You’re viewing 5 of 12 executives. Get the full list »

Precision BioSciences Board Members (5)

Name Representing Role Since Contact
Info
Derek Jantz Precision BioSciences Co-Founder, Chief Scientific Officer & Board Member 000 0000
Matthew Kane Precision BioSciences Co-Founder, Chief Executive Officer & Board Member 000 0000
Robert Adelman MD venBio Board Member 000 0000
Tony Yao Self Board Member 000 0000

1 Former Board Member

You’re viewing 4 of 5 board members. Get the full list »